Sanofi Growth Slows In Emerging Markets But South America Accelerates: Emerging Markets Earnings Round Up (Part 2)

In a recurring feature, PharmAsia News combs through quarterly earnings reports to bring you highlights on emerging markets. In Q3, Sanofi SA reported emerging markets sales up 6.8% in the third quarter, a slower pace compared to 12.3% growth it achieved in the previous quarter.

In part 1, PharmAsia News covered GlaxoSmithKline PLC, Novo Nordisk A/S, and Eli Lilly & Co, which also reported...